Reminder: Hearing On Generic Biotechs
Make a commentBy Ed Silverman // March 26th, 2007 // 7:57 am
The starting time is 10 am and it will be held by the House Committee on Oversight and Government Reform, which is headed by Henry Waxman, who wants to explore how the FDA can find ways to approve generic biotechs.
The witness list includes the FDA’s Janet Woodcock, as well as reps from drugmakers, academica, AARP, a big PBM and patient advocacy groups.